ArticleAnnals of hepato-biliary-pancreatic surgery2017

Assessing the role of everolimus in reducing hepatocellular carcinoma recurrence after living donor liver transplantation for patients within the UCSF criteria: re-inventing the role of mammalian target of rapamycin inhibitors.

Ashok Thorat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.